The reported patient effect of thrombosis is listed in the supera instruction for use as a potential adverse effect of peripheral percutaneous intervention.The device was not returned for evaluation.The lot history record (lhr) for this product could not be reviewed and a similar complaint query could not be performed because the product was not returned for evaluation and the lot number was not reported.The reported patient effect of thrombosis is listed in the supera instruction for use as a potential adverse effect of peripheral percutaneous intervention.Based on the information provided, a conclusive cause for the reported stent material deformation and subsequent patient effects could not be determined.It may be possible that the supera stent was subjected to stress/fatigue or repetitive movement due to anatomical conditions and location of the implant; however, this could not be confirmed.The additional therapy/non-surgical treatment, surgical procedure, treatment with medications and hospitalization were due to case circumstances.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
An abbott vascular medical affairs expert reviewed the details of the case and the angiographic images provided.The results of the review are as follows: the supera self expanding stent has an obvious twist.It is unclear as to whether this happened during deployment or between the placement and return visit to the hospital.The cause is unknown.Based on the information provided and review of the provided angiographic images, a conclusive cause for the reported stent material deformation and subsequent patient effects could not be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|